Wordt geladen...
The novel glutamine antagonist prodrug JHU395 has antitumor activity in malignant peripheral nerve sheath tumor
The carbon and nitrogen components of glutamine are used for multiple biosynthetic processes by tumors. Glutamine metabolism and the therapeutic potential of glutamine antagonists (GA), however, are incompletely understood in malignant peripheral nerve sheath tumor (MPNST), an aggressive soft tissue...
Bewaard in:
| Gepubliceerd in: | Mol Cancer Ther |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7007868/ https://ncbi.nlm.nih.gov/pubmed/31594823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-19-0319 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|